1.Vildagliptin: a novel oral anti-diabetic drug in the treatment of type 2 diabetes mellitus
Chinese Journal of Endocrinology and Metabolism 2011;27(7):后插1-后插4
Vildagliptin is a potent and selective inhibitor of dipeptidyl peptidase-4 (DPP-4), which can prevent the cleavage and inactivation of glucagon-like peptide-1 (GLP-1), and thus increases the plasma level of intact GLP-1. Such action promotes the insulin secretion from β cell and suppresses inappropriately glucagon secretion from α cell in a glucose-dependent manner. Vildagliptin used as monotherapy or in combination with other antidiabetic drugs can effectively reduce HbA1C, fasting and postprandial plasma glucose, and improve islet β cell and α cell function in type 2 diabetes mellitus patients with extremely few hypoglycemia and comparable adverse effects with placebo, but no weight gain. The unique drug action, reliable clinical efficacy, and favorable safety and tolerability of vildagliptin make it a novel oral antidiabetic drug for the treatment of type 2 diabetes mellitus.
2.Features of radionuclide myocardial perfusion imaging in patients with homozygous familial hypercholesterolemia
Jian JIAO ; Luya WANG ; Hongzhi MI ; Tiantian MOU ; Junqi LI ; Xiaoli ZHANG
Chinese Journal of Nuclear Medicine and Molecular Imaging 2018;38(6):381-384
Objective To evaluate the features of myocardial perfusion imaging (MPI) in patients with homozygous familial hypercholesterolemia (HoFH) and its influence factors.Methods Forty-two consecutive HoFH patients (21 males,21 females;average age:(14.8±8.4) years) were retrospectively enrolled in this study from June 2010 to November 2016.Diagnosis was proved by clinical and chromosome tests,and all patients underwent ATP stress and rest 99Tcm-methoxyisobutylisonitrile (MIBI) SPECT MPI with a two-day protocol.Summed stress score (SSS) and summed rest score (SRS) were acquired,and summed difference score (SDS;SSS-SRS) was calculated.Relations between SSS,SRS,SDS and age,lipid profile were analyzed.Two-sample t test,x2 test,multiple linear regression analysis and multivariate logistic regression were used to analyze the data.Results There were 24 patients with positive MPI results (SSS≥1),and females (76.2%,16/21) showed more positive MPI results than males (38.1%,8/21;x2=6.22,P<0.05).Eighteen patients had negative MPI results.There were 6,8,10 patients with MPI positive results in < 10 years group (n =14),10-18 years group (n =14) and ≥ 19 years group,respectively (x2=2.33,P>0.05).Positive electrocardiograph (ECG) in ATP stress test was observed in 9 females (42.9%,9/21) and 3 males (14.3%,3/21;x2 =4.20,P<0.05).Sixty-three (8.8%,63/714) abnormal myocardial perfusion segments (SSS≥ 1) were found,which was mainly (60.3%,38/63) distributed in myocardial regions supplied by left anterior descending branch (LAD).SSS was positively correlated with age and high density lipoprotein cholesterol (HDLC).SRS,SDS were positively correlated with HDLC and age respectively.Multivariate logistic regression analysis indicated that the female was the only independent risk factor to predict positive MPI (odds ratio=5.2,95% CI:1.363-19.774).Conclusions In HoFH patients,abnormal myocardial perfusion had a rising trend with age increasing.Female patients are more likely to have abnormal MPI.Abnormal myocardial perfusion segments are mainly located in myocardial regions supplied by LAD.Age and gender are influence factors of abnormal MPI in HoFH patients.
3.Detection of High Methylation of p15(INK4B) and p16(INK4A) Genes in Multiple Myeloma
Hongtao FAN ; ; Xiuzhi GUO ; Qiong WU ; Tao ZHOU ; Guangxiao TAN ; Luya WANG ; Xueli ZHANG ; Gengxin LUO ; Minhua XU
Journal of Experimental Hematology 2000;8(4):271-274
To study the action, characteristics and expression of high methylation of p15(INK4B) and p16(INK4A) genes in multiple myeloma (MM), the sensitive methylation specific PCR method was employed to detect the hypermethylation of p15(INK4B) and p16(INK4A) in 24 patients with MM. Results showed that the methylation incidence of p15(INK4B) and p16(INK4A) genes were 70.8% (17/24) and 58.3% (14/24) in the MM patients, with the products of 148 bp and 150 bp fragments, respectively. The methylation of p15(INK4B) and p16(INK4A) genes were simultaneously happened in MM patients of plasmocytoma type with two cases at II phase and two cases at III phase. The simultaneous non-methylation of p15(INK4B) and p16(INK4A) genes were founded in five cases of MM patients, all of the tumor cells were of small plasmocyte type with mature differention. Conclusion suggested that there were high incidence of methylation of p15(INK4B) and p16(INK4A) genes in patients with MM. Hypermethylation can be detected in the early stage of disease, which was associated with its progress. It indicated a bad prognosis when methylation happended simultaneously in the two genes. Methylation of p15(INK4B) and p16(INK4A) genes may be related to the pathogeny of MM.